Literature DB >> 33622487

Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs.

Hamzah Z Farooq, Daniela M Cirillo, Doris Hillemann, David Wyllie, Marieke J van der Werf, Csaba Ködmön, Vlad Nikolayevskyy.   

Abstract

We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and repurposed tuberculosis drugs exists, but its availability is limited.

Entities:  

Keywords:  Europe; Mycobacterium tuberculosis; antimicrobial resistance; bacteria; drug susceptibility; drugs; public health; respiratory infections; testing; tuberculosis; tuberculosis and other mycobacteria

Mesh：

Substances：

Year:  2021        PMID： 33622487      PMCID： PMC7920658          DOI： 10.3201/eid2703.204418

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  8 in total

1.  A cost comparison of amikacin therapy with bedaquiline, for drug-resistant tuberculosis in the UK.

Authors:  Kavina Manalan; Nathan Green; Amber Arnold; Graham S Cooke; Martin Dedicoat; Marc Lipman; Angela Loyse; Tom S Harrison; Onn Min Kon
Journal:  J Infect       Date:  2019-09-21       Impact factor: 6.072

2.  'Those who cannot remember the past are condemned to repeat it': Drug-susceptibility testing for bedaquiline and delamanid.

Authors:  Claudio U Köser; Florian P Maurer; Katharina Kranzer
Journal:  Int J Infect Dis       Date:  2019-02-25       Impact factor: 3.623

Review 3.  Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives.

Authors:  T Schön; P Miotto; C U Köser; M Viveiros; E Böttger; E Cambau
Journal:  Clin Microbiol Infect       Date:  2016-11-01       Impact factor: 8.067

4.  Diagnosis of tuberculosis and drug resistance: what can new tools bring us?

Authors:  F Drobniewski; V Nikolayevskyy; Y Balabanova; D Bang; D Papaventsis
Journal:  Int J Tuberc Lung Dis       Date:  2012-07       Impact factor: 2.373

5.  External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study.

Authors:  Vladyslav Nikolayevskyy; Doris Hillemann; Elvira Richter; Nada Ahmed; Marieke J van der Werf; Csaba Kodmon; Francis Drobniewski; Sabine Ruesch-Gerdes
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

6.  Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope.

Authors:  Rajendra Prasad; Nikhil Gupta; Amitabh Banka
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

7.  Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study.

Authors:  Koné Kaniga; Akio Aono; Emanuele Borroni; Daniela Maria Cirillo; Christel Desmaretz; Rumina Hasan; Lavania Joseph; Satoshi Mitarai; Sadia Shakoor; Gabriela Torrea; Nazir Ahmed Ismail; Shaheed V Omar
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

8.  Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

Authors:  Caroline Allix-Béguec; Irena Arandjelovic; Lijun Bi; Patrick Beckert; Maryline Bonnet; Phelim Bradley; Andrea M Cabibbe; Irving Cancino-Muñoz; Mark J Caulfield; Angkana Chaiprasert; Daniela M Cirillo; David A Clifton; Iñaki Comas; Derrick W Crook; Maria R De Filippo; Han de Neeling; Roland Diel; Francis A Drobniewski; Kiatichai Faksri; Maha R Farhat; Joy Fleming; Philip Fowler; Tom A Fowler; Qian Gao; Jennifer Gardy; Deborah Gascoyne-Binzi; Ana-Luiza Gibertoni-Cruz; Ana Gil-Brusola; Tanya Golubchik; Ximena Gonzalo; Louis Grandjean; Guangxue He; Jennifer L Guthrie; Sarah Hoosdally; Martin Hunt; Zamin Iqbal; Nazir Ismail; James Johnston; Faisal M Khanzada; Chiea C Khor; Thomas A Kohl; Clare Kong; Sam Lipworth; Qingyun Liu; Gugu Maphalala; Elena Martinez; Vanessa Mathys; Matthias Merker; Paolo Miotto; Nerges Mistry; David A J Moore; Megan Murray; Stefan Niemann; Shaheed V Omar; Rick T-H Ong; Tim E A Peto; James E Posey; Therdsak Prammananan; Alexander Pym; Camilla Rodrigues; Mabel Rodrigues; Timothy Rodwell; Gian M Rossolini; Elisabeth Sánchez Padilla; Marco Schito; Xin Shen; Jay Shendure; Vitali Sintchenko; Alex Sloutsky; E Grace Smith; Matthew Snyder; Karine Soetaert; Angela M Starks; Philip Supply; Prapat Suriyapol; Sabira Tahseen; Patrick Tang; Yik-Ying Teo; Thuong N T Thuong; Guy Thwaites; Enrico Tortoli; Dick van Soolingen; A Sarah Walker; Timothy M Walker; Mark Wilcox; Daniel J Wilson; David Wyllie; Yang Yang; Hongtai Zhang; Yanlin Zhao; Baoli Zhu
Journal:  N Engl J Med       Date:  2018-09-26       Impact factor: 91.245
  8 in total
  2 in total

Review 1.  Drug-resistant tuberculosis: advances in diagnosis and management.

Authors:  Gunar Günther; Nunurai Ruswa; Peter M Keller
Journal:  Curr Opin Pulm Med       Date:  2022-02-25       Impact factor: 2.868

Review 2.  Anti-Mycobacterial Drug Resistance in Japan: How to Approach This Problem?

Authors:  Keisuke Kamada; Satoshi Mitarai
Journal:  Antibiotics (Basel)       Date:  2021-12-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.